Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A STUMP

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Neuropharmacology|January 8, 2013
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic targetSophie Parmentier-Batteur, Peter H Hutson, Karsten Menzel, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.
Journal of Medicinal Chemistry|October 3, 1999
N-arylpiperazinone inhibitors of farnesyltransferase: discovery and biological activityT M Williams, J M Bergman, K Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2015
Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraineBrendan M Crowley, Craig A Stump, Diem N Nguyen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
[(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide ReceptorIan M Bell, Steven N Gallicchio, Craig A Stump, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2017
Structural characterization of nonactive site, TrkA-selective kinase inhibitorsHua-Poo Su, Keith Rickert, Christine Burlein, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Neuropharmacology|January 8, 2013
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic targetSophie Parmentier-Batteur, Peter H Hutson, Karsten Menzel, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonistsIan M Bell, Rodney A Bednar, John F Fay, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.
Journal of Medicinal Chemistry|October 3, 1999
N-arylpiperazinone inhibitors of farnesyltransferase: discovery and biological activityT M Williams, J M Bergman, K Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2015
Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraineBrendan M Crowley, Craig A Stump, Diem N Nguyen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
[(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide ReceptorIan M Bell, Steven N Gallicchio, Craig A Stump, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2017
Structural characterization of nonactive site, TrkA-selective kinase inhibitorsHua-Poo Su, Keith Rickert, Christine Burlein, et al.
Pageof 13